Gold gains on its immunity to the coronavirus

Ole Hansen

Head of Commodity Strategy

Summary:  Gold stays bid as renewed stock market weakness and further spreading of the coronavirus continue to negatively impact markets and the economic outlook


Precious metals stay bid in response to a continued collapse in global bond yields and worries that the stock market rout is not over yet. This as the real economic impact of disrupted global supply lines have only just started to be felt. Another worry is the risk that the U.S., the world’s biggest economy, due to what looks like a broken healthcare system and an unhealthy working culture could be on the cusp of a major outbreak of the new coronavirus.

The debasement currently being undertaken by central banks, led by the US Federal Reserve, has pushed U.S. 10-year real yields to a -0.50%, a seven-year low. A very importantly development for gold which does not offer a yield.

The emergency rate cut from the U.S. Federal Reserve on Monday to 1.25% is, according to market expectations, likely to be followed by another 50 bp cut at the regular FOMC meeting on March 18. So far the low point stands at 0.35% which could be reached before the November U.S. elections.

The elevated speculative position held by funds has raised some concerns about a sharp correction should volatility spike again like it did last week. When volatility spikes funds targeting a certain level of volatility in their portfolio are forced to reduce exposure across the board. This development hit gold last week when the Cboe VIX jumped to 40% (currently 37%).

Spiking volatility aside some concerns has also been raised about the sustainability of a near record long. It reached 285,000 lots in the week to February 25, before the mentioned VIX spike undoubtedly took some length out of the market. However, looking at the length relatively to the size of the cake, i.e. the open interest, we find the position not yet elevated compared with levels reached during the past 12 years.

Spot gold is currently heading for the highest daily close in seven years above $1660/oz. With another 50bp rate cut already priced in the prospect for additional gains depend on continued safe-haven demand. With this in mind the U.S. stock market performance hold the key to further gains.

Source: Saxo Bank
Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

Saxo Capital Markets HK is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo Capital Markets HK Limited holds a Type 1 Regulated Activity (Dealing in securities); Type 2 Regulated Activity (Dealing in Futures Contract) and Type 3 Regulated Activity (Leveraged foreign exchange trading) licenses (CE No. AVD061). Registered address: Rooms 2001-02, 20/F York House, The Landmark, 15 Queen's Road Central, Hong Kong

By clicking on certain links on this site, you are aware and agree to leave the website of Saxo Capital Markets, proceed on to the linked site managed by Saxo Group and where you will be subject to the terms of that linked site.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

Please note that the information on this site and any product and services we offer are not targeted at investors residing in the United States and Japan, and are not intended for distribution to, or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Please click here to view our full disclaimer.